
GL Stock Forecast & Price Target
GL Analyst Ratings
Bulls say
Globe Life is positioned for durable fundamental strength because its lower-middle and middle-income customer base, exclusive distribution, and below-peer underwriting risk support steady premium growth, with 1Q26 life net sales up 6% and health sales up 58%. Management’s outlook also points to low-double-digit EPS growth, helped by improving American Income recruiting, Liberty National growth, rising net investment income, and sequentially better health margins as Medicare Supplement rate increases earn in. Capital returns add further upside, as buyback guidance was raised to $725-$775M for 2026 and Bermuda could contribute roughly $150M of dividends across 2026-27, while valuation still sits below historical averages.
Bears say
Globe Life is facing a weaker fundamental profile because elevated medical claim severity in Evry and Medicare supplement irregularities are pressuring near-term earnings, with a ~$16M 3Q loss and about $7M of prior-period claims catch-up contributing to the miss. Even though 4Q severity may improve and Medicare rate increases begin in 2Q27, management’s own commentary implies volatility can persist into 2027, while disciplined underwriting, reinsurance, and diversification are not yet enough to ensure stable results. The outlook is further tempered by lower 2026E EPS of $15.49 and 2027E EPS of $16.40, alongside only partial relief from buybacks and excess investment income amid risks from slower sales growth, lapsation, and margin deterioration.
This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.
GL Analyst Forecast & Price Prediction
Start investing in GL
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Globe Life Inc (GL) Forecast
GL Analyst Forecast & Price Prediction
Start investing in GL
Order type
Buy in
Order amount
Est. shares
0 shares